Cue biopharma to participate in fireside chat at the cantor global healthcare conference

Boston, aug. 21, 2025 (globe newswire) -- cue biopharma, inc. (nasdaq: cue), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and modulate disease-specific t cells for the treatment of autoimmune disease and cancer, today announced that it will participate in a fireside chat at the cantor global healthcare conference being held in new york, september 3-5, 2025.
CUE Ratings Summary
CUE Quant Ranking